• COVID-19 Resources
  • About
  • Subscribe
  • Promotions
  • Advertise
  • Contact Us
  • June 1, 2025

Milwaukee Courier Weekly Newspaper

"THE NEWSPAPER YOU CAN TRUST SINCE 1964"

  • News
  • Editorials
  • Education
  • Urban Business
  • Health
  • Religion
  • Upcoming Events
  • Classifieds
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MILWAUKEE COURIER

Share:

  • Click to share on Facebook (Opens in new window) Facebook
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To Help Patients Save Money, Congress Needs to Tackle the Middlemen in Health Care

January 27, 2023

By Sally C. Pipes

Sally C. Pipes

As a Republican-controlled House of Representatives with a small majority opens for business in January, one member has especially big ideas for saving patients money on prescription drug costs — and the research to back it up.

A year ago, Rep. James Comer (R-KY) released a comprehensive report on the role of pharmacy benefit managers in the nation’s healthcare system. The result does not make for pleasant reading. It is largely a tale of how greedy middlemen have taken advantage of existing legal loopholes and lax oversight to create an industry that raked in $28 billion in profits in 2019 — while providing no actual healthcare to patients.

Insurers use pharmacy benefit managers to negotiate with drug makers on terms for the inclusion of medications in insurance plan coverage. In fact, however, the three biggest PBMs, which account for nearly 80 percent of prescription claims, are co-owned alongside respective massive insurers like Cigna and pharmacy behemoths like CVS Caremark.

The result is an interlocking daisy chain for extracting maximum profit from consumers and payers such as employers and federal and state governments — all while deflecting blame for increasing drug costs away from themselves and onto drug makers.

There’s evidence that to remain competitive with PBMs, drug makers have set list prices higher in expectation of large forthcoming discounts — a move that passes none of the discounts directly to patients but allows PBMs to extract increased revenue for their bottom line.

Insurers, meanwhile, charge coinsurance payments and count toward deductibles patient out-of-pocket costs based on the list price of the medication — not the discounted price the insurers actually pay. Insurers like this arrangement just fine because it allows them to crank up their own revenue without raising premiums.

Insurers and their PBMs also pressure consumers to obtain medications through their own respective pharmacy groups. That can take the relatively benign form of an endless barrage of emails from insurers urging beneficiaries to switch their prescriptions in-house. In more severe cases, PBMs can discriminate against independent pharmacies by offering lower reimbursement rates and excluding them from insurer networks.

Altogether, this conduct has become so parasitic that more than 50% of each dollar spent on brand-name medicines now goes to middlemen entities.

If lawmakers and regulators at the Federal Trade Commission and elsewhere were doing their jobs, this would all be illegal and patients would save big. Instead, many lawmakers have been happy to look the other way while pointing a finger at “Big Pharma” and pocketing campaign contributions from PBMs and allied grifters.
Rep. Comer hits the nail on the head with his main reform push: meaningful transparency among PBMs. Consumers deserve to know who’s paying what to whom for prescription drugs.

Healthcare reform must allow patients to make informed choices about their care. Greater transparency for PBM practices is the starting point. Next up should be the shocking requirement that drug discounts ostensibly for patients get passed on to patients, not sucked up by middlemen.

Sally C. Pipes (@sallypipes) is president, CEO, and Thomas W. Smith fellow in Health Care Policy at the Pacific Research Institute. Her latest book is False Premise, False Promise: The Disastrous Reality of Medicare for All (Encounter 2020). Follow her on Twitter @sallypipes.

Share:

  • Click to share on Facebook (Opens in new window) Facebook
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Popular Interests In This Article: Health Care Middlemen, Health Insurance, Pharmacy Benefit Managers, Prescription Drug Prices, Sally C. Pipes

Read More - Related Articles

  • Senator Baldwin Applauds Announcement of 15 More Prescription Drugs to be Negotiated for Lower Prices
  • White House Celebrates Record ACA Enrollment as Trump Administration Plans to Overhaul Health Care
  • The Healthcare System: A Battle Against Denial
  • Milwaukee County Executive David Crowley and Congresswoman (D-VA) Jennifer McClellan Host Roundtable Event on Kamala Harris’s Efforts to Lower Medical Costs
  • Biden and Harris Reunite to Highlight Drug Pricing Deal
Become Our Fan On Facebook
Find Us On Facebook


Follow Us On X
Follow Us On X

Editorials

Lakeshia Myers
Michelle Bryant
Dr. Kweku Akyirefi Amoasi formerly known as Dr. Ramel Smith

Journalists

Karen Stokes

Topics

Health Care & Wellness
Climate Change
Upcoming Events
Obituaries
Milwaukee NAACP

Politicians

David Crowley
Cavalier Johnson
Marcelia Nicholson
Governor Tony Evers
President Joe Biden
Vice President Kamala Harris
Former President Barack Obama
Gwen Moore
Milele A. Coggs
Spencer Coggs

Classifieds

Job Openings
Bid Requests
Req Proposals
Req Quotations
Apts For Rent

Contact Us

Milwaukee Courier
2003 W. Capitol Dr.
Milwaukee, WI 53206
Ph: 414.449.4860
Fax: 414.906.5383

Copyright © 2025 · Courier Communications | View Privacy Policy | Site built and maintained by Farrell Marketing Technology LLC
We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.